Tag: lexaria bioscience corp
July 11, 2019
Lexaria Bioscience Enters CBD License Agreement with Universal Hemp
Lexaria Bioscience Enters CBD License Agreement with Universal Hemp July 10, 2019
Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages
Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a... June 4, 2019
Lexaria Bioscience Announces new DehydraTECH Innovation, Files New Patents
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)(the "Company" or "Lexaria"), a drug delivery platform innovator, has discovered improved performance characteristics of a... May 28, 2019
Combining Lexaria’s DehydraTECH(TM) with Nanotech Delivers Increased Quantities of CBD into Brain Tissue
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces recent animal testing proves that... May 21, 2019
Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship
1906 fast-acting edibles products, powered by Lexaria's DehydraTECH technology, will expand across the US in 2019 and 2020 May 15, 2019
Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, has proven in animal testing that... May 7, 2019